SNAI1 and ovarian cancer: Given this evidence, future genomic studies in the form of whole-genome chromatin immunoprecipitation sequencing (ChIP-seq) for Snail binding sites in ovarian cancer cells derived from patient samples would be highly beneficial in determining the direct and indirect regulatory mechanisms of Snail.